Suppr超能文献

兰地洛尔对大鼠再灌注缺血心脏机械和代谢变化的影响。

Effects of landiolol on mechanical and metabolic changes in rat reperfused ischaemic hearts.

作者信息

Sakanashi Makiko, Sakanashi Mayuko, Sugahara Kazuhiro, Sakanashi Matao

机构信息

Department of Anaesthesiology, School of Medicine, Faculty of Medicine, University of the Ryukyus, Nishihara, Okinawa, Japan.

出版信息

Clin Exp Pharmacol Physiol. 2007 Jan-Feb;34(1-2):55-60. doi: 10.1111/j.1440-1681.2007.04543.x.

Abstract
  1. The aim of the present study was to clarify the effects of landiolol, a short-acting selective beta(1)-adrenoceptor blocking agent, on mechanical and metabolic changes in postischaemic perfused hearts. 2. Rat isolated hearts (n = 30) were randomly separated into non-ischaemic or ischaemic groups. The latter group was further divided into Krebs'-Henseleit solution (KHS)- and landiolol (30, 100 or 300 micromol/L)-treated groups. Ischaemic hearts were subjected to 25 min global ischaemia and 20 min reperfusion under atrial pacing. Time-course changes in left ventricular (LV) end-diastolic pressure (LVEDP), LV developed pressure (LVDP), peak positive velocity of change of LV pressure (LVdP/dt(max)) and coronary flow were observed along with tissue contents of adenosine triphosphate (ATP), creatine phosphate, inorganic phosphate (Pi), malondialdehyde (MDA) and lactate dehydrogenase (LDH) release in coronary effluent. The effects of landiolol on rat isolated aortic preparations under KCl contraction were also investigated. 3. Ischaemia-reperfusion significantly impaired cardiodynamics, such as LVEDP, LVDP and LVdP/dt(max), decreased myocardial ATP content and increased Pi and LDH release. In the 30 micromol/L landiolol-treated group, cardiovascular parameters impaired by ischaemia-reperfusion and increased LDH release were further exacerbated and myocardial MDA content was significantly increased. In the 300 micromol/L landiolol-treated group, cardiac contractile dysfunction was improved and myocardial MDA, ATP and Pi contents were preserved. All measurements in the 100 micromol/L landiolol-treated group were similar to those in the ischaemic KHS group. Furthermore, significant relaxations of isolated aortic preparations were obtained with landiolol 30-1000 micromol/L, suggesting a possible calcium antagonism with landiolol. 4. In conclusion, landiolol, at low concentrations, aggravated myocardial ischaemia-reperfusion injuries, whereas at high concentrations it ameliorated them. The former effect may be mediated by the production of reactive oxygen species, whereas the latter may involve calcium antagonist activity.
摘要
  1. 本研究的目的是阐明短效选择性β₁肾上腺素能受体阻滞剂兰地洛尔对缺血后灌注心脏机械和代谢变化的影响。2. 将30只大鼠离体心脏随机分为非缺血组或缺血组。后一组进一步分为 Krebs-Henseleit 溶液(KHS)处理组和兰地洛尔(30、100或300 μmol/L)处理组。缺血心脏在心房起搏下进行25分钟全心缺血和20分钟再灌注。观察左心室(LV)舒张末期压力(LVEDP)、左心室发展压力(LVDP)、左心室压力变化最大正向速度(LVdP/dt(max))和冠状动脉血流的时程变化,以及冠状动脉流出液中三磷酸腺苷(ATP)、磷酸肌酸、无机磷酸盐(Pi)、丙二醛(MDA)和乳酸脱氢酶(LDH)释放的组织含量。还研究了兰地洛尔对氯化钾收缩下大鼠离体主动脉制剂的影响。3. 缺血再灌注显著损害心脏动力学,如LVEDP、LVDP和LVdP/dt(max),降低心肌ATP含量,增加Pi和LDH释放。在30 μmol/L兰地洛尔处理组中,缺血再灌注损害的心血管参数和增加的LDH释放进一步加重,心肌MDA含量显著增加。在300 μmol/L兰地洛尔处理组中,心脏收缩功能障碍得到改善,心肌MDA、ATP和Pi含量得以保留。100 μmol/L兰地洛尔处理组的所有测量结果与缺血KHS组相似。此外,30 - 1000 μmol/L兰地洛尔可使离体主动脉制剂显著舒张,提示兰地洛尔可能具有钙拮抗作用。4. 总之,低浓度的兰地洛尔会加重心肌缺血再灌注损伤,而高浓度时则可改善这些损伤。前者的作用可能由活性氧的产生介导,而后者可能涉及钙拮抗活性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验